IGNATIA AMARA (HOMEOLAB USA INC)


Welcome to the PulseAid listing for the IGNATIA AMARA drug offered from HOMEOLAB USA INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC
NON-PROPRIETARY NAME: IGNATIA AMARA
SUBSTANCE NAME: STRYCHNOS IGNATII SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


IGNATIA AMARA HUMAN OTC DRUG Details:

Item DescriptionIGNATIA AMARA from HOMEOLAB USA INC
LABELER NAME: HOMEOLAB USA INC
DEA SCHEDULE:
ACTIVE STRENGTH: 3([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-1024_dbed9a33-71d8-437a-81d2-4df1e7e76d73
PRODUCT NDC: 60512-1024
APPLICATION NUMBER:

Other STRYCHNOS IGNATII SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BrandStorm HBCIgnatia Amara 30c
Energique, Inc.Ignatia
HOMEOLAB USA INCIGNATIA AMARA
Hyland’sIGNATIA AMARA
Laboratoires BoironIgnatia amara
Natural Health SupplyShock Grief
Paramesh Banerji Life Sciences LLCIgnatia amara 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncIGNATIA AMARA
Schwabe North America, Inc.Ignatia amara
Seroyal USAIGNATIA AMARA
STANDARD HOMEOPATHIC COMPANYIGNATIA AMARA
Washington Homeopathic ProductsIgnatia amara